Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fractional RF and Tretinoin for Striae Distensae
NCT05461755Phase 2Completed
- Start
- Nov 2022
- Primary completion
- Jul 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial of tretinoin in striae distensae (SD) (4 arms). Primary endpoint: Global Aesthetic Improvement Scale at 20 weeks. Started Nov 2022; status: completed.
02
Drugs
tretinoin
03
Conditions
striae distensae (SD)
Beyond the preview
Go deeper on NCT05461755.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05461755.